HWA
EDIT icon

HHM Wealth Advisors’s Editas Medicine EDIT Stock Holding History

HHM Wealth Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-205
Closed -$4K – 790
2022
Q1 		$4K Hold
205
– – ﹤0.01% 629
2021
Q4 		$5K Sell
205
-45
-18% -$1.55K ﹤0.01% 576
2021
Q3 		$10K Buy
250
+170
+213% +$9.31K ﹤0.01% 489
2021
Q2 		$5K Buy
+80
New +$2.96K ﹤0.01% 525

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

HHM Wealth Advisors's EDIT Position: Q2 2022 in Review

HHM Wealth Advisors sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 205 shares — an estimated $4K sold.

HHM Wealth Advisors first reported a position in EDIT in Q2 2021 and held it in 4 quarters. The position peaked at $10K in Q3 2021. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • HHM Wealth Advisors reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • HHM Wealth Advisors sold 205 Editas Medicine shares in Q2 2022, an estimated $4K.
  • HHM Wealth Advisors first reported a position in Editas Medicine in Q2 2021 and held it in 4 quarters.
  • HHM Wealth Advisors's Editas Medicine position peaked at $10K in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on HHM Wealth Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.